Experimental Drug Trial Leads to Remarkable Recovery for Paralyzed Man
A Pennsylvania man, Larry Williams, has shown significant improvement in mobility after participating in an experimental peptide drug trial, NVG-291, following a spinal cord injury.
Williams, 58, was involved in a mountain biking accident where he struck a tree, resulting in a broken C4 to C6 vertebrae in his cervical spine, despite wearing a helmet.
The injection has helped him move more freely after his accident.
The NVG-291 trial, which is currently in phase 2, has been tested on eligible patients, with some reporting notable outcomes, including improved movement for those with spinal cord injuries.
Author's summary: Experimental drug helps paralyzed man walk again.